Views

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

WHITE PAPER – Biotech and Breakthroughs in Immuno-Oncology

Key Points

  • Paradigm-shift in disease management with the approval of immuno-oncology agents, namely, checkpoint inhibitors, created a major shift in how patients with cancers are treated.
  • The significant clinical impact of checkpoint inhibitors led to what some have seen as a goldrush, others as a bubble, toward clinical development of immunotherapies.
  • Immuno-oncology agents have not by and large cured most patients in most cancers, hence new immunotherapeutic agents and combinations are needed.
  • Over the past 5 years, much of the BioPharma industry’s focus has been on expanding the range of immuno-oncology agents and combinations.

Complete the information below to download your free copy of the White Paper

For further information about our range of services

Contact Us

Share this

Related Articles

EVENT – Cancer Progress, Virtual | May 4-6 2021
19 January 2021
EVENT – Cancer Progress, Virtual | May 4-6 2021

Join us at Cancer Progress, Virtual May 4-6 2021 ❝ Inspiring Cancer Progress through engaged stakeholder dialogue ❞

WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now
19 January 2021
WHITE PAPER – Early Asset Commercialization Strategy: The Time is Now

The biotech industry is in an exciting period of growth and innovation, the number of new products being registered continues to increase year on year, with a significant proportion of these being novel, first in class medicines.

15 Breakthrough drug innovations (infographic)
06 October 2020
15 Breakthrough drug innovations (infographic)

In this simple infographic we describe 15 drug innovations throughout recent history, from the first successful vaccine developed in the late 18th century to today’s personalized gene therapy treatments.

What is Medical Communications?
22 June 2020
What is Medical Communications?

The importance of medical communications within the pharmaceutical and healthcare sector should not be underestimated. Discover why and exactly what it is.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today

Contact us